BioAscent
Newhouse, United Kingdom bioascent.com
From their website, Nov 2026
Work here? Claim this listing
About
BioAscent is a drug discovery CRO based in Newhouse, Scotland, UK. It provides integrated discovery services for biopharma customers, including assay development, screening, medicinal and synthetic chemistry, computational chemistry, protein production, structural biology, and compound management. The company also manages customer compound libraries and supports projects from target work through to preclinical and clinical candidates.
Services
De novo assay development
Designs and develops new assays for drug discovery projects.
Assays & in vitro testing
Assay optimisation and miniaturisation
Optimises existing assays and scales them down for efficient screening.
Assays & in vitro testing
Biochemical, biophysical and cellular assay development
Develops bespoke biochemical, biophysical, and cellular assays for target interrogation and hit identification.
Assays & in vitro testing
Target analysis & bespoke screening strategies
Designs and interprets assay cascades and screening strategies for a target.
Assays & in vitro testing
Compound screening
Runs screening campaigns including HTS, MTS, fragment, focused, iterative, diversity-based and virtual screening.
Assays & in vitro testing
Medicinal chemistry
Designs and synthesises ligands through hit generation, hit-to-lead, and lead optimisation.
Synthetic chemistry
Provides route design and tailored synthesis, including building blocks, multi-step synthesis, asymmetric synthesis, parallel synthesis, and reference molecules.
In silico discovery and AI
Applies computational chemistry, CADD, cheminformatics, modelling, and data analysis to drug discovery projects.
Physicochemical profiling & DMPK
Supports discovery DMPK work and connects medicinal chemistry with ADME and pharmacokinetic data.
ADME, DMPK & toxicology
Protein production
Provides bespoke protein expression, purification, and characterisation.
Protein production
Surface plasmon resonance (SPR) & biophysics
Measures biomolecular interactions and binding kinetics using SPR and related biophysical methods.
Assays & in vitro testing
Structural biology
Uses X-ray crystallography for target validation, hit validation, SAR support, and fragment screening.
Assays & in vitro testing
Compound management
Stores, manages, reformats, and ships compound libraries in liquid and solid formats.
In-house diversity, fragment & chemogenomic libraries
Provides access to in-house diversity, fragment, and chemogenomic libraries for screening and phenotypic studies.
External library selection & sourcing
Designs and sources custom screening libraries from supplier databases.
Mitochondrial biology
Uses mitochondrial profiling assays to de-risk programs and assess mitochondrial liabilities.
Assays & in vitro testing
Gpcr drug discovery
Supports GPCR projects with assay development, screening, medicinal chemistry, in-silico methods, and integrated project delivery.
Assays & in vitro testing
Accelerating CNS drug discovery
Supports CNS drug optimisation with computational and chemistry approaches focused on blood-brain-barrier challenges.
Integrated drug discovery
Combines biology, chemistry, computational, and compound management capabilities to support drug discovery projects from target to candidate.
Bespoke assay development
Develops and optimises biochemical, biophysical, and cellular assays for hit identification, mechanistic profiling, and medicinal chemistry support.
Assays & in vitro testing
Mitochondrial biology in drug discovery
Uses translational mitochondrial assays to assess bioenergetic effects, mechanism of action, and mitochondrial liabilities.
Assays & in vitro testing
CNS drug discovery
Supports central nervous system drug discovery with computational, chemistry, and integrated optimisation approaches.
Biochemical, Biophysical & Cellular Assay Development
Develops and validates assays for drug discovery programs across biochemical, biophysical, and cellular formats.
Assays & in vitro testing
- What to send
- Protein samples · Compound libraries · Customer compounds · Target or structure information for custom library design · Compound libraries in liquid and solid formats
Capabilities
As they state on their website or in their listing.
- Processes
- Small molecule · Recombinant protein · SPR · HTS · Small molecules · ADME
- Capacity
- 125K IP-free molecules · 86,000 compounds held as solid stock · Over 1.5 million compounds managed for customers · Libraries of up to 250k in size · 96-well plates · 384-well plates · 1536-well plates · Three individually housed, environmentally controlled -20°C stores · In-house diversity library of 125K IP-free molecules · 86,000 compounds also held as solid stock · Multiple HTS and fragment screens using libraries of up to 250k in size · Three individually housed environmentally controlled -20°C stores
7 more
96, 384 and 1536-well plate formats · Libraries up to 250k in size · Over 100,000 screening plates · 96-well plate formats · 384-well plate formats · 1536-well plate formats · Three individually housed -20°C stores - Data supplied
- NMR · LC-MS
Equipment
- Biacore 8K
- Seahorse XF
- LC-MS
- UPLC
- SFC
- NMR
- Diamond Light Source synchrotron
- Mosaic from Titian
- Robotic systems
- Surface plasmon resonance (SPR)
Industries served
- Biotechnology
- Pharmaceutical
- Academia
Company
- Type
- CRO
- Founded
- 2013
Locations
- Based in
- Newhouse, United Kingdom
- Sites
- Newhouse, United Kingdom
- Serves
- around the world, customers from around the world, global customers, partners
Contacts
- Phone
- +44 (0) 1698 534002
Similar labs
Work here? Claim this listing